BDBM283249 4-{2-(4-amino-piperidin-1-yl)-1- methyl-6-oxo-5-[1-(2,2,2-trifluoro- ethyl)-1H-pyrazol-4-yl]-1,6- dihydro-pyrimidin-4-yl}-2-fluoro- benzonitrile::US10023543, Example 34::US10207999, Example 34::US10328077, Example 34::US10548896, Example 34::US10849898, Example 34::US10960005, Example 34::US11084793, Example 34::US9573930, Example 34::US9771329, Example 34::US9776974, Example 34

SMILES Cn1c(nc(-c2ccc(C#N)c(F)c2)c(-c2cnn(CC(F)(F)F)c2)c1=O)N1CCC(N)CC1

InChI Key InChIKey=BDWAHZDJZINOHA-UHFFFAOYSA-N

Data  12 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 283249   

TargetLysine-specific histone demethylase 1A(Homo sapiens (Human))
Celgene Quanticel Research

US Patent
LigandPNGBDBM283249(4-{2-(4-amino-piperidin-1-yl)-1- methyl-6-oxo-5-[1...)
Affinity DataIC50: <100nMAssay Description:This assay determines the ability of a test compound to inhibit LSD-1 demethylase activity. E. coli expressed full-length human LSD-1 (Accession numb...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent